2003.-The mucosal lining of the human intestine is constantly bathed in a milieu of commensal gut flora, the vast majority of these being nonpathogenic microorganisms. Here, we demonstrate that microbial-epithelial cell interactions not only affect proinflammatory pathways but also influence ␤-catenin signaling, a key component in regulating epithelial cell proliferation. The nonpathogenic Salmonella strain PhoP c activates the ␤-catenin signaling pathway of human epithelia via a blockade of ␤-catenin degradation. Normal ␤-catenin ubiquitination necessary for constitutive ␤-catenin degradation is abolished, allowing the accumulation and translocation of ␤-catenin to the nucleus. Transcriptional activation mediated by the ␤-catenin/T cell factor complex increases c-myc expression and enhances cell proliferation. We also show that the Salmonella effector protein AvrA is involved in modulating this ␤-catenin activation. These data suggest that nonvirulent bacterial-epithelial interactions can influence ␤-catenin signaling and cell growth control in a manner previously unsuspected. host defense; inflammation; cellular proliferaton ␤-CATENIN IS A MULTIFUNCTIONAL protein that has been shown to play an important role in both embryonic development and neoplasia (18, 19, 27) . The involvement of ␤-catenin in tumorigenesis was first established in human colonic oncogenesis (9, 20) , and, subsequently, ␤-catenin mutations have been reported in a variety of human tumors. Under basal conditions ␤-catenin is synthesized and constitutively degraded, thus maintaining appropriate cytoplasmic levels. Without this constitutive ␤-catenin degradation, cytoplasmic levels rise and allow ␤-catenin to accumulate in the nucleus. Once in the nucleus, ␤-catenin binds to the transcription T cell factor (TCF) and activates multiple target genes, namely c-myc, cyclin D1, matrix metalloproteinase-7, cyclooxygenase-2, gastrin, CD44, and P-glycoprotein, which modulate the development and progression of apoptosis, cell proliferation, and in some instances, colorectal carcinoma (1, 15, 26) . It is becoming increasingly clear that tight regulation of ␤-catenin synthesis and degradation is crucial to maintaining cellular homeostasis.
It has recently been observed that interactions between the intestinal epithelium and nonpathogenic Salmonella strains can attenuate the host innate immune response by preventing the ubiquitination of IB␣ and thus the activation of the NF-B proinflammatory pathway (17) . Although the NF-B and ␤-catenin/TCF signaling pathways are independent, both IB and ␤-catenin are regulated by phosphorylation at similar consensus NH 2 -terminal serines (4, 25) . Phosphorylation at this site targets both proteins for ubiquitination by the same ubiquitin ligase complex, E3-SCF ␤-TrCP , ultimately resulting in proteasomal degradation of the ubiquitinated proteins (4, 25) . Interestingly, the consequences of E3-SCF ␤-TrCP regulation of these two pathways can be very different. E3-SCF ␤-TrCP -mediated degradation of IB leads to the induction of NF-B activity and proinflammatory responses, whereas E3-SCF ␤-TrCP -mediated degradation of cytoplasmic ␤-catenin inhibits TCFdependent transcriptional activation (4, 25) . It is likely that the nonpathogenic bacterial-induced effect is mediated by inhibition of E3-SCF
␤-TrCP
. In a recent publication (3), it was shown that the blockade of IB ubiquitination can be attributed to the bacterial effector protein AvrA, which is injected into the host cell by the type III secretory system of nonvirulent Salmonella. AvrA is a novel target of the centisome 63 type III protein secretion system of S. enterica. It shares sequence similarity with YopJ of the animal pathogen Yersinia pseudotuberculosis and AvrRxv of the plant pathogen Xanthomonas campestris pv. Vesicatoria (5) . AvrA protein from S. typhimurium inhibits activation of the key proinflammatory NF-B transcription factor in human epithelial cells. Besides IB, the other known substrate of the E3 ligase is ␤-catenin, which has been implicated in epithelial growth control. Thus we hypothesize that bacterial-epithelial interactions that block NF-B degradation could also influence ␤-catenin-mediated signaling of epithelial cell growth.
In the present study, we have used the human epithelia HeLa cell model system to examine the effects of nonpathogenic bacteria on the ␤-catenin signaling pathway. HeLa cells provide an excellent model system because they are known to have an intact ␤-catenin signaling pathway, grow rapidly, and are easy to transiently transfect. In addition, a great deal of literature has been published concerning the ␤-catenin pathway in HeLa cells, providing a good foundation for comparison. We also used human intestinal cell lines T84, HT29-C19A, and rat small intestinal epithelial cell IEC-18 to further determine our hypothesis. We report here that the nonpathogenic bacteria S. typhimurium PhoP c activates the ␤-catenin signaling pathway by attenuating ␤-catenin ubiquitination and enhances cell proliferation by allowing ␤-catenin-TCF interactions that result in increased c-myc expression. For the first time, we show that Salmonella effector, AvrA, is involved in modulating this ␤-catenin activation. Our observations suggest that bacterialhost interactions might induce long-term cellular responses in addition to the more transient inhibition of acute inflammatory responses, utilizing bacteria-derived factors to activate host machinery. , and Escherichia coli F18 (a flagellated nonpathogenic strain) were used as controls in some experiments. Bacterial growth conditions were as follows: nonagitated microaerophilic bacterial cultures were prepared by inoculating 10 ml of Luria Bertanibroth with 0.01 ml of a stationary phase culture followed by overnight incubation (ϳ18 h) at 37°C as previously detailed (10) .
MATERIALS AND METHODS

Bacteria
Cell culture. HeLa cells and HT29-C19A were grown in DMEM (high glucose, 4.5 g/l) containing 5% (vol/vol) fetal bovine serum, 50 g/ml streptomycin, and 50 U/ml penicillin. T84 epithelial cells (American Type Culture Collection, Manassas, VA) were grown in 1:1 DMEM and Ham's F-12 medium supplemented with 15 mM HEPES (pH 7.5), 14 mM NaHCO 3, antibiotics, and 5% neonatal calf serum. The rat small intestinal IEC-18 cell line was grown in DMEM (high glucose, 4.5 g/l) containing 5% (vol/vol) fetal bovine serum, 0.1 U/ml insulin, 50 g/ml streptomycin, and 50 U/ml penicillin. IEC-18 cells were used at 60 -70% confluence between passages 20 and 30 in 96-well plates for cell proliferation assay.
Immunoblotting of ubiquitinated proteins. Equal numbers of cells were plated on six-well plates. Cells were colonized as previously detailed (8) with equal numbers of the indicated bacteria in HBSS for 30 min before the addition of 0.5 M MG262 for the times indicated. Cells were rinsed twice in ice-cold HBSS, and lysed in protein loading buffer (50 mM Tris, pH 6.8, 100 mM dithiothreitol, 2% SDS, 0.1% bromphenol blue, 10% glycerol). Equal volumes of total cell lysis were separated by SDS-PAGE, transferred to nitrocellulose, and processed for immunoblotting with ubiquitin-protein conjugates antibody (Affiniti Research Products, Exeter, UK), and ␤-catenin antibody (Transduction Laboratories). Immune complexes were visualized with the appropriate peroxidase-conjugated antibodies and developed by using an ECL kit (Amersham Biosciences).
Immunoblotting. Cells were colonized with equal numbers of the indicated bacteria for 30 min, washed with HBSS, and incubated in DMEM containing gentamicin (500 g/ml) for the times indicated. Cells were rinsed twice in ice-cold HBSS, lysed in a lysis buffer [in mM: 50 Tris, pH 8.0, 150 NaCl, 5 EDTA with a protease inhibitor cocktail and 1% Triton X-100, and complete Mini (1 tablet/10 ml, Roche)], and sonicated. Protein concentrations were measured with Bio-Rad protein assay solution. Equal amounts of total cell proteins were loaded and separated by SDS-PAGE and processed for immunoblotting with ␤-catenin, c-myc, ␤-actin (H-196) antibodies (Santa Cruz Biotechnology, Santa Cruz, CA), or ␤-actin (AC-15) antibody from Sigma.
Immunostaining. Cells were incubated with WT S. typhimurium or PhoP c for 30 min, washed, and incubated in medium containing gentamicin for 24 h. As a positive control for ␤-catenin nuclear translocation, some cells were incubated with the proteasome inhibitor 25 M N-acetyl-leu-leu-norleucinal (Affiniti, UK) for 12 h before staining. Cells were rinsed three times in PBS, fixed for 10 min in 3.7% paraformaldehyde, and then rinsed three times in PBS. The cells were then permeabilized for 10 min with 0.2% Triton X-100 and rinsed three times with PBS containing 10% bovine serum albumin. Permeabilized cells were then incubated with mouse anti-␤-catenin antibodies (Transduction Laboratories) for 1 h at 37°C. After cells were stained with primary antibodies, they were rinsed three times with PBS and incubated with the appropriate FITC-conjugated secondary antibodies (Jackson Immunoresearch Laboratories, West Grove, PA) for 1 h at 37°C. The sample was covered with 10 l of SlowFade reagent (Molecular Probes, Eugene, OR) followed by a coverslip, and the edges were sealed to prevent drying. Specimens were examined with a Zeiss LSM410 scanning laser confocal microscope.
EMSA. Cells were scraped in a lysis buffer (10 mM HEPES, pH 7.9, 10 mM KCl, 1 mM DTT) containing a protease-inhibitor cocktail, and were incubated for 15 min on ice. Nuclei were collected by centrifugation at 2,000 g for 5 min at 4°C and resuspended in 50 l of the same buffer without KCl but with 420 mM NaCl. After a 30-min incubation on ice, nuclear debris were removed by centrifugation at 13,000 g for 10 min at 4°C, and the supernatants were collected and stored at Ϫ80°C before use. The DNA sequences of the double-stranded oligonucleotide specific of TCF were 5Ј-TCGAC-CCTTTGATCTTACC-3Ј and 5Ј-TCGAGGTAAGATCAAAGGG-3Ј (based on Ref. 9a). Complementary strands were annealed and double-stranded oligonucleotides were labeled with [ 32 P]dCTP by using the Klenow fragment of DNA polymerase (GIBCO-BRL). Five micrograms of nuclear proteins were incubated for 10 min at 4°C in a binding buffer (in mM: 20 Tris⅐HCl, pH 7.9, 5 MgCl 2, 0.5 DTT, and 0.5 EDTA with 20% glycerol) in the presence of 2 g of poly(dI-dC). The extracts were then incubated for 30 min at 4°C with 10,000 cycles/min of 32 P-labeled TCF probes. The samples were loaded on a 5% native polyacrylamide gel and run in 0.5ϫ TBE buffer. The ␤-catenin/TCF specific band was confirmed by competition with a 500-fold excess of the respective unlabeled probe and mouse anti-␤-catenin antibody.
TCF transcriptional activity assay. Cells were transiently cotransfected with 1-g pGL3-OT (TCF-responsive reporter with WT TCF binding site), or pGL3-OF (mutant TCF binding site) using lipofectin reagent according to the manufacturer's instructions (Life Technology). PRL-TK vector (Promega) was used as an internal control reporter. Cells were colonized with equal numbers of bacteria for 30 min, washed, and incubated in DMEM for 6 h. Luciferase activity was monitored by using the dual luciferase assay system (Promega).
Cell proliferation assays. Equal numbers of cells were plated on 96-well plates. Cells were colonized as previously detailed (8) with equal numbers of the indicated bacteria in HBSS for 30 min. Cells were rinsed twice in ice-cold HBSS and incubated in DMEM containing gentamicin (500 g/ml) for 24 h, and then incubated for an additional 4 h in medium containing MTT or 5-bromo-2Ј-deoxyuridine (BrdU). Proliferation assays were performed according to the manufacturer's specifications for the MTT cell proliferation kit (Roche) and cell proliferation BrdU labeling kit (Roche).
RT-PCR. Total bacterial RNA was purified with Qiagen RNeasy Mini Kit. Qiagen Onestep RT-PCR kit was used for AvrA and Malate dehydrogenase amplification. Primers for AvrA PCR were designed from the published sequence (GenBank accession no. AE008830), as follows: 5Ј primers (5Ј-ACCGCTATCGCTGTTCC-3Ј) and 3Ј primer (5Ј-GTATTATTTGCCATCGTGTTTATT-3Ј). Use of the primers yielded a 1200-bp segment. For amplification of Malate dehydrogenase (2), an 849-bp segment, the PCR primers are as follows: the 5Ј primers (5Ј-ATGAAAGTCGCAGTCCTC-3Ј) and the 3Ј primer (5Ј-ATATCTYTTCAGCGTATCCAGC-3Ј). DNA sequencing was used to confirm the identity of the PCR products.
RESULTS
Colonization with nonpathogenic Salmonella attenuates ␤-catenin ubiquitination. We first investigated whether colonization of epithelial cells with Salmonella would promote an increase in the higher molecular weight ubiquitinated forms of ␤-catenin as has been previously seen for the IB␣ protein (17) . To be able to visualize ubiquitinated proteins, cells had to be treated with a proteasome inhibitor (MG262 or MG132), because all ubiquitin-modified proteins are targeted for rapid proteasomal degradation, making them inherently short-lived and difficult to capture. Treating cells with the proteasome inhibitor prevents degradation of ubiquitinated proteins and results in the appearance of multiple higher molecular weight forms when probed by immunoblot. HeLa cells were incubated with or without Salmonella for 30 min, washed, and then treated with the proteasome inhibitor MG262 for the times indicated. To prevent protein degradation after cell lysis, cells were lysed directly in SDS-reducing loading buffer (12) . A ␤-catenin immunoblot of equal amounts of total cellular protein revealed that in control cells treated with MG262 alone, ubiquitinated ␤-catenin persisted during the 3-h incubation as expected (Fig. 1A, MG262, arrowheads) . During the same interval, cells colonized with WT Salmonella showed a slight increase in ubiquitinated forms of ␤-catenin (Fig. 1A) . In contrast, cells colonized by the nonpathogenic Salmonella strain PhoP c completely lacked the ubiquitinated ␤-catenin bands (Fig. 1A) . This indicates that PhoP c colonization had blocked ␤-catenin ubiquitination before any stabilization by the proteasome inhibitor. Using an antibody to ubiquitinprotein conjugates, we also determined that general cellular protein ubiquitination was unaffected by bacterial colonization (data not shown), suggesting that the effect of PhoP c was specific for ␤-catenin. Our finding in the HeLa cell line is consistent with the previous report from our laboratory (17) in the T84 cell line. When T84 model epithelia were colonized by WT S. typhimurium, followed by the addition of proteasome inhibitor, ubiquitination of ␤-catenin could also be seen. However, colonization with the anti-inflammatory Salmonellae, again followed by addition of proteasome inhibitor, totally abrogated the appearance of ubiquitinated ␤-catenin over 3 h (17) . These results support our hypothesis that S. typhimurium PhoP c mediate an anti-inflammatory state by inhibition of ubiquitination and could suggest that the effects of this class of bacteria may extend beyond reduction of inflammation and influence ␤-catenin pathway.
␤-catenin degradation is attenuated by nonpathogenic Salmonella. We then sought to determine whether the observed blockade of ␤-catenin ubiquitination by nonpathogenic Salmonella could also prevent ␤-catenin degradation. Cells were colonized with bacteria for 30 min, washed, and incubated in medium containing gentamicin to prevent further bacterial growth. We examined ␤-catenin levels by immunoblot over a 24-h period, and as expected, ␤-catenin protein levels remained constant in untreated cells and decreased in a time-dependent fashion in cells colonized with WT Salmonella (Fig. 1, B and  C) . This decrease in ␤-catenin stability in cells incubated with WT Salmonella correlates nicely with the slight increase in ubiquitinated ␤-catenin seen in Fig. 1, A and B . In contrast, we Equal amounts of total cell lysates were analyzed for ␤-catenin levels by immunoblot. Ubiquitinated (Ub) ␤-catenin is indicated by arrowheads. WT, wild type. B: ratio of ubiquitinated ␤-catenin/control protein ␤-actin. Protein amounts (band intensity) for Ub ␤-catenin and ␤-actin were determined by densitometry. C: cells were incubated for the times indicated with or without Salmonellae, and total cell lysates were analyzed for ␤-catenin levels by immunoblot. D: protein amounts (band intensity) for total ␤-catenin in B were determined by densitometry. Data are from a single experiment and are representative of 3 separate experiments.
saw ␤-catenin initially decrease from control levels and then rebound in cells colonized with PhoP c (Fig. 1, B and C) . Because bacterial colonization has many effects on the cells, we could not directly compare the total ␤-catenin levels between treated and untreated cells, but rather were interested in whether the levels remained constant (no treatment), decreased (WT), or increased (PhoP c ) over time. It is known that the cellular stores of ␤-catenin are continually being ubiquitinated and degraded at a rate equivalent to that of synthesis, thus maintaining steady-state levels. However, because ubiquitination is inhibited by PhoP c colonization, ␤-catenin synthesis is able to recover quickly from the initial loss of the previously ubiquitinated ␤-catenin. We examined ␤-catenin levels over a 24-h period in the human intestinal T84 cell line. We found the similar trend of ␤-catenin expression as in HeLa cell line after bacterial colonization. (Fig. 2) . ␤-catenin protein levels remained constant in untreated cells and decreased in a timedependent fashion in cells colonized with WT Salmonella (Fig.  2, A and B) . In contrast, we saw ␤-catenin initially decrease from control levels and then rebound in cells colonized with PhoP c (Fig. 2, A and B ). These data demonstrate that colonization with nonpathogenic Salmonella PhoP c inhibits the ␤-catenin degradation by attenuating its ubiquitination.
Colonization with nonvirulent Salmonella promotes nuclear translocation of ␤-catenin and activates the ␤-catenin/TCF signaling pathway. Our next objective was to determine whether the protective effects of PhoP c colonization on ␤-catenin would alter its cellular distribution. In cells receiving no treatment, ␤-catenin immunofluorescent staining was mainly localized to the cell periphery at the plasma membrane (Fig. 3) . Cells that were colonized by WT Salmonella for 24 h exhibited changes in cell morphology, and ␤-catenin was not as clearly membrane-localized, but was still excluded from nuclei. However, colonization with nonpathogenic PhoP c induced nuclear translocation of ␤-catenin (Fig. 3 ) that was very similar to the positive control cells treated with the proteasome inhibitor ALLN (Fig. 3, bottom) . Taken together, these results clearly demonstrate that PhoP c colonization not only stabilizes ␤-catenin by preventing its degradation but also allows its accumulation and translocation into the nucleus.
It is well known that once in the nucleus, ␤-catenin can interact with the TCF family of transcription factors to form specific DNA binding complexes. We then sought to ascertain whether the nuclear localization of ␤-catenin would trigger transcriptional activity using a luciferase reporter gene assay for TCF activation. EMSA showed that special ␤-catenin/TCF DNA binding complexes in PhoP c colonized HeLa cells. Much less of this complex was noticed in cells colonized by WT S. typhimurium. No complex was detected in control cells (Fig.  4A) . A ␤-catenin/TCF specific band was confirmed by competition with ␤-catenin antibody (data not shown). To test whether this complex could activate transcription, a luciferase reporter assay of TCF activation was used. Cells were transfected with a plasmid containing either the WT TCF binding site (pGL3-OT) or a defective TCF binding site (pGL3-OF) upstream of the SV40 promoter and luciferase reporter gene and then challenged with bacterial colonization. In addition to WT and PhoP c Salmonella strains, nonpathogenic Salmonella InvA and nonpathogenic E. coli F18 were used to control for the effect bacterial colonization might have on the luciferase background. In cells transfected with the defective TCF construct, TCF-induced luciferase activity was not significantly different than cells with no treatment (Fig. 4B, pGL3-OF) . In cells transfected with WT TCF construct, the luciferase activity was substantially higher in cells colonized by PhoP c , compared with those colonized by WT Salmonella, or the bacterial controls InvA Ϫ and E. coli F18 (Fig. 4B, pGL3-OT) . These data indicate that colonization by nonvirulent Salmonella PhoP c induces ␤-catenin to translocate to the nucleus, bind TCF, and activate transcription of TCF responsive genes.
Nonvirulent Salmonella colonization regulates cell proliferation. Under normal circumstances, when ␤-catenin binds to the transcription factor TCF and activates target genes, cell proliferation is enhanced. We then sought to determine how cell proliferation would be influenced by bacterial colonization. The MTT cell proliferation assay measures cellular metabolic activity on the basis of the reduction of the tetrazolium salt MTT to a water-insoluble formazan dye by viable cells. Cells were incubated for 30 min with equal numbers of the indicated bacteria and then assayed 24 h later. We found that cell proliferation was enhanced only with nonvirulent Salmonella PhoP c but not by colonization with WT or nonpathogenic Salmonella InvA Ϫ bacteria (Fig. 5A) . Additionally, we also measured BrdU incorporation into newly synthesized DNA to confirm the cell proliferation effects seen with the MTT assay. HeLa cells colonized with PhoP c incorporated as much BrdU as the cells that received no treatment, a level which was approximately eightfold greater than cells colonized with the WT Salmonella in HeLa cell line (Fig. 5B) others such as AvrA have yet to be determined. We (3) recently reported that Salmonella effector protein AvrA inhibits the activation of the key proinflammatory transcription factor NF-B by preventing the ubiquitination of IB␣. To determine whether expression of AvrA also mediates the inhibition of ␤-catenin ubiquitination (Fig. 1 , ubiquitinated ␤-catenin levels similar to cells infected with WT Salmonella were observed (Fig. 6 , AvrA Ϫ ). Exposure to PhoP c AvrA Ϫ /AvrA ϩ decreased the ubiquitinated ␤-catenin to levels similar to those seen with PhoP c (Fig. 6 ). Because the transcomplemented AvrA is not expressed to the same level as endogenous AvrA in PhoP c , we did not expect a complete reversal of ubiquitination in the presence of PhoP c AvrA Ϫ /AvrA ϩ . These data suggest that the expression of Salmonella AvrA effector in PhoP c is able to prevent the ubiquitination of ␤-catenin, because its removal restores normal ubiquitination.
Expression of c-myc is transcriptionally regulated by ␤-catenin/TCF and is known to have an essential function in cellular growth and proliferation (6) . In both normal and neoplastic cells, c-myc promotes cellular division by inhibiting cyclindependent kinase inhibitors (16) . We then evaluated the effect of AvrA on c-myc expression in cells that were colonized with various strains of Salmonella. As early as 18 h after exposure to WT Salmonella, c-myc levels had decreased approximately twofold below cells that received no treatment (Fig. 7, A and  B) . During the same time period, cells colonized with PhoP c were able to maintain c-myc levels similar to those of control cells. Whereas cells colonized with Salmonella lacking AvrA had reduced c-myc expression similar to those colonized with WT Salmonella (Fig. 7 , AvrA Ϫ ). Our data demonstrate that colonization with PhoP c induces c-myc expression to a degree such that it overwhelms the twofold decrease caused by bacterial colonization.
Because AvrA plays such a significant role in regulating ␤-catenin signaling, we then asked whether there is a difference in AvrA expression levels among the various Salmonella strains. Currently, there is no antibody available for the AvrA protein. We isolated total RNA from maximally invasive cultures and used semiquantitative RT-PCR to determine whether there was a significant difference (2-fold or greater) in AvrA message levels. As expected, all of the Salmonella strains, except AvrA Ϫ , expressed AvrA message (data not shown). Interestingly, there was no apparent difference among the AvrA mRNA levels in WT, PhoP c , or InvA Ϫ . It may be that our assay is not sensitive enough to detect more subtle differences that may have a profound effect on AvrA protein levels. Alternatively, the differences that we observed between WT and PhoP c colonized cells may be a result of differences in AvrA protein injected into the cells. This will have to be tested once an AvrA antibody becomes available.
DISCUSSION
The goal of this study was to demonstrate that nonpathogenic bacteria influences ␤-catenin signaling in intestinal epithelial cells. This was achieved by colonizing epithelial cells with either pathogenic or nonpathogenic strains of Salmonella and then examining the signaling activity of ␤-catenin. We (17) have previously reported that the nonpathogenic Salmonella strain PhoP c can attenuate proinflammatory signals by preventing the ubiquitination of IB␣. Hence we focused our attention on Salmonella PhoP c and identified the bacterial effector protein AvrA, which can also inhibit the ubiquitination of ␤-catenin. Using biochemical, genetic, and cell biological methods, we demonstrated that AvrA expression is required for PhoP c to increase ␤-catenin/TCF activation of c-myc and enhance cell proliferation.
Our observations presented here suggest that bacterial-host interactions might induce long-term cellular responses in addition to the more transient inhibition of acute inflammatory responses, utilizing bacteria-derived factors to activate host machinery. Signaling through ␤-catenin is controlled by its regulated degradation. In normal cells, ␤-catenin is constitutively phosphorylated by Gsk-3␤ kinase, ubiquitinated by E3 ligase, and degraded in the proteasome (Fig. 8A) . However, after nonpathogenic bacterial colonization, ubiquitination is inhibited, presumably via AvrA inhibition of the ubiquitin ligase E3 by a currently undetermined mechanism. As a result, ␤-catenin is not degraded but rather accumulates and enters the nucleus. Once in the nucleus, ␤-catenin binds to the transcription factor TCF and activates multiple target genes, including c-myc (Fig. 8B) . The effects of these target genes have been shown by others (15) to regulate cell proliferation, apoptosis, and cell fate.
Recently, others (13, 24) have reported the stabilization of ␤-catenin by the bacterial product LPS in myeloid cells. The authors found that LPS activates the phosphatidylinositol 3-kinase (PI3-kinase) and inactivates GSK-3, resulting in the accumulation of ␤-catenin. This occurs via a Toll-like receptor 4-mediated signaling event linked to the PI3-kinase pathway rather than the traditional Wnt-signaling pathway (13) . In human intestinal cells, it has also been reported that a bacterial toxin, B. fragilis toxin, triggers ␤-catenin nuclear localization. Subsequently, c-myc transcription and translation are induced, and persistent cellular proliferation ensues, mediated in part by ␤-catenin/TCF-dependent transcriptional activation (28) . However, these reported bacterial effects on ␤-catenin signaling do not require direct bacterial-host cell cross talk as is seen with Salmonella. We are the first to demonstrate that direct microbial-epithelial cell interactions not only affect rapid proinflammatory pathways but also influence more latent ␤-catenin signaling, a key component in regulating epithelial cell proliferation. Bacteria-derived effector proteins, such as AvrA, inhibit host machinery and regulate the ␤-catenin/TCF pathway in human epithelia. ␤-catenin behaves as a potent oncogene product, and its accumulation has been implicated in tumorigenesis in a variety of human cancers (8, 14, 22) . This link between the ␤-catenin signaling pathway and bacterial-epithelial interaction suggests a mechanistic relationship between pathways that control intestinal inflammation and those that regulate cell proliferation. These interactions appear to be capable of influencing the control of cell growth and perhaps oncogenesis.
For the first time, we show that Salmonella effector protein AvrA regulates the ␤-catenin/TCF pathway in human epithelia. It is clear that AvrA inhibits ubiquitination, which in turn influence the ubiquitin-mediated proteolysis of ␤-catenin, perhaps Bcl-2 and p53, which are also regulated by the ubiquitinproteolysis system (21, 23 ). Thus our current focus is to understand the mechanism by which AvrA regulates the activity of the E3 ligase and how by doing so, also modulates the stability several important substrates.
PhoP-PhoQ is a two-component regulatory system that controls the expression of over 40 genes essential for S. typhimurium virulence and survival within macrophages. PhoP c is a PhoP-PhoQ constitutive mutation that increases the expression of PhoP-activated genes and represses the synthesis of ϳ20 proteins encoded by PhoP-repressed genes (11) . The apparent differences in ␤-catenin ubiquitination between WT Salmonella and nonpathogenic PhoP c suggest that bacterial genes regulated by the PhoP-PhoQ regulon are involved in the inhibition of ␤-catenin ubiquitination. Currently, few of the genes controlled by the PhoP-PhoQ regulon have been assigned functions (reviewed in Ref. 7) , and it is not known whether any of them may regulate AvrA; however, this is an active area of investigation. In summary, we have established that nonpathogenic Salmonella do influence ␤-catenin signaling. Using epithelial model systems, we have demonstrated that S. typhimurium PhoP c requires AvrA expression to inhibit the constitutive ubiquitination and degradation of ␤-catenin. This bacterialinduced inhibition allows ␤-catenin/TCF stimulated expression of c-myc and enhances cell proliferation. Although the exact mechanism of AvrA action is not known, further characterization of AvrA may provide insight into how aberrant signals from nonpathogenic gut bacteria may lead to long-term changes in cell proliferation and possibly oncogenesis. These questions are currently being examined in polarized epithelial cell model systems.
